Not Yet Recruiting PHASE2 INTERVENTIONAL 1-arm
NCT07147088
Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma. (CASTLE-ZS-03)
Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-03): A Single-arm, Phase 2 Trial.
Sponsor: Fudan University
Conditions
Advanced Intrahepatic Cholangiocarcinoma
Interventions
Cryoablation Famitinib SHR-1701
Updated 1 time since 2025 Last updated: Aug 21, 2025 Started: Sep 1, 2025 Primary completion: Sep 1, 2027 Completion: Sep 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07147088, this PHASE2 trial focuses on Advanced Intrahepatic Cholangiocarcinoma and remains actively recruiting participants. Sponsored by Fudan University, it has been updated 1 time since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Fudan University
Data source: Fudan University
For direct contact, visit the study record on ClinicalTrials.gov .